First Trust Advisors LP Increases Stock Position in Globe Life Inc. $GL

First Trust Advisors LP raised its stake in shares of Globe Life Inc. (NYSE:GL) by 45.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 305,963 shares of the company’s stock after acquiring an additional 95,677 shares during the period. First Trust Advisors LP owned approximately 0.38% of Globe Life worth $43,743,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Mather Group LLC. purchased a new position in shares of Globe Life during the 3rd quarter worth approximately $28,000. CYBER HORNET ETFs LLC purchased a new stake in Globe Life in the second quarter valued at approximately $28,000. Assetmark Inc. lifted its stake in Globe Life by 777.8% during the second quarter. Assetmark Inc. now owns 237 shares of the company’s stock worth $29,000 after purchasing an additional 210 shares in the last quarter. MUFG Securities EMEA plc acquired a new position in Globe Life during the second quarter worth $31,000. Finally, Quent Capital LLC purchased a new position in shares of Globe Life during the third quarter worth $36,000. 81.61% of the stock is owned by hedge funds and other institutional investors.

Globe Life Stock Down 1.3%

GL stock opened at $141.02 on Thursday. The company’s 50 day moving average price is $142.09 and its 200 day moving average price is $139.02. The firm has a market capitalization of $11.09 billion, a price-to-earnings ratio of 10.02 and a beta of 0.46. Globe Life Inc. has a fifty-two week low of $109.38 and a fifty-two week high of $152.71. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The firm had revenue of $1.52 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter in the prior year, the firm earned $3.14 EPS. The firm’s revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities research analysts anticipate that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Friday, April 3rd will be given a dividend of $0.33 per share. This is an increase from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $1.32 annualized dividend and a dividend yield of 0.9%. Globe Life’s dividend payout ratio is presently 9.38%.

Insider Buying and Selling at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 12,500 shares of the firm’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total value of $1,809,750.00. Following the sale, the chief executive officer directly owned 35,868 shares in the company, valued at $5,192,969.04. This trade represents a 25.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Mark A. Blinn sold 1,750 shares of Globe Life stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $147.91, for a total value of $258,842.50. Following the sale, the director directly owned 3,372 shares of the company’s stock, valued at $498,752.52. This trade represents a 34.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 92,186 shares of company stock worth $13,358,379. 1.51% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

GL has been the subject of a number of research reports. Weiss Ratings raised Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, February 13th. TD Cowen restated a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. Morgan Stanley reaffirmed an “overweight” rating and issued a $176.00 target price on shares of Globe Life in a research report on Monday, December 15th. JPMorgan Chase & Co. boosted their price target on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Finally, Wells Fargo & Company increased their price target on shares of Globe Life from $170.00 to $171.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 25th. Eight analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $171.33.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.